Commentary: Emerging Bias in the Treatment of Posttraumatic Stress Disorder
J Clin Psychiatry 2012;73(3):304-306
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
The author comments on new information on treatment of posttraumatic stress disorder in veterans, which is presented in the Lund et al and Bernardy et al articles published in the same issue. Recent trends in benzodiazepine prescription patterns are discussed. The suppositions set forth in the articles as to the appropriateness of and alternatives to benzodiazepine medications are challenged.
J Clin Psychiatry 2012; 73(3):320-326 © 2012; 73(3): Physicians Postgraduate Press, Inc